This report is pretty much where I thought we would be. Australia flatlining, but due to digital implementation plans of facilities requiring upgrade so delaying uptake. Clearly decided larger facilities are best target so I think we are seeing drop off in small facilities and 1% decline is a timing issue, IMO, others may disagree.
UK is roaring ahead and if they are only at 8%, and taking 30% as the easy hanging fruit which is Australia's penetration, then we have a lot of growth there. 30% of the US market is a nice target
Bestmed a great reseller deal - takes pressure off Painchek itself, for a cost, but likely to lead to faster take up.
Databank continues to accumulate - a valuable asset
and this is the bit I have banged on about as a possibility for sometime
Pointclickcare Partnership is going to work well for PCK. They have 50% of the 2,000,000 long care beds.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)